4-Chlorobenzo[b]thiophene CAS 66490-33-3 Maʻemaʻe >98.0% (GC) Brexpiprazole Intermediate Factory

ʻO ka wehewehe pōkole:

Inoa Kemika: 4-Chlorobenzo[b]thiophene

CAS: 66490-33-3

Maʻemaʻe: >98.0% (GC)

Ke ʻano: wai kala ʻole

Ka waena o Brexpiprazole (CAS: 913611-97-9)

ʻO ke kūlana kiʻekiʻe, ka hana kālepa

E-Mail: alvin@ruifuchem.com

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

ʻO Ruifu Chemical Supply Brexpiprazole Intermediates
Brexpiprazole CAS 913611-97-9
7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo[b]thiophene CAS 5118-13-8
1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3
7-(4-Chlorobutoxy)quinolin-2(1H)-hoʻokahi CAS 913613-82-8
4-Chlorobenzo[b]thiophene CAS 66490-33-3

Na Waiwai Kemika:

Inoa Kimia	4-Chlorobenzo[b]thiophene
Nā huaʻōlelo like	4-Chloro-Benzo[b]thiophene;4-Chloro-1-Benzothiophene;4-Chlorobenzothiophene
Helu CAS	66490-33-3
Helu CAT	RF-PI1983
Kūlana Kūʻai	Ma ka waihona, hoʻonui ʻia a hiki i nā tona
ʻĀpana Molekala	C8H5ClS
Kaumaha Molecular	168.64
Brand	Kemika Ruifu

Nā kikoʻī:

'ikamu	Nā kikoʻī
Ka nana aku	Wai kala ʻole
Maʻemaʻe / Kaʻina Hanana	>98.0% (GC)
Huina paumaele	<2.00%
Infrared Spectrum	Kūlike i ka hoʻolālā
NMR	Kūlike i ka hoʻolālā
Kūlana hoʻāʻo	Kūlana ʻoihana
Hoʻohana	Ka waena o Brexpiprazole (CAS: 913611-97-9)

Pūʻolo a me ka waiho ʻana:

Pūʻolo: Fluorinated Bottle, 25kg/Drum, a i ʻole e like me ka makemake o ka mea kūʻai aku

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai

Pono:

FAQ:

Noi:

ʻO 4-Chlorobenzo[b]thiophene (CAS: 66490-33-3) kahi mea waena o Brexpiprazole (CAS: 913611-97-9).ʻO Brexpiprazole kahi lāʻau antipsychotic hou e lawelawe nei ma ke ʻano he serotonin ® dopamine activity modulator a ua hōʻike i ka pono ma ke ʻano he lāʻau hoʻohui i nā maʻi me ka maʻi depressive nui (MDD).Hōʻike ka lāʻau lapaʻau i kahi ʻano lāʻau pharmacological kūʻokoʻa, e hana ana ma ke ʻano he agonist ʻāpana o ka serotonin 5-HT1A a me ka dopamine D2 receptors a ma ke ʻano he antagonist piha o 5-HT2A a me noradrenaline α1B / 2C receptors, me ka subnanomolar binding affinity.ʻO ka lāʻau lapaʻau, i hoʻomohala ʻia e Otsuka a me Lundbeck, ua ʻae ʻia ma 2015 e ka FDA no ka mālama ʻana i ka schizophrenia a ma ke ʻano he lāʻau hoʻohui no ke kaumaha.Ua manaʻo nui ʻia ʻo Brexpiprazole he mea pani i ka lāʻau lapaʻau antipsychotic o Otsuka aripiprazole (inoa kālepa Abilify) i pau ka patent i ʻAukake 2014.